- Approval Id
- 0873ccbec56958f6
- Drug Name
- APO-NAPRO-NA TABLET 275 MG
- Product Name
- APO-NAPRO-NA TABLET 275 MG
- Approval Number
- SIN07136P
- Approval Date
- 1992-09-23
- Registrant
- PHARMAFORTE SINGAPORE PTE LTD
- Licence Holder
- PHARMAFORTE SINGAPORE PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- TABLET, FILM COATED
- Dosage
- <p><strong>Dosage:</strong> The recommended starting dose of naproxen sodium for adults is two 275 mg tablets followed by one 275 mg tablet every 6 to 8 hours, as required. The total daily dose should not exceed 5 tablets (1375 mg).</p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>Indications:</strong> For the relief of mild to moderately severe pain accompanied by inflammation in conditions such as musculoskeletal trauma and postdental extraction. Also indicated for the relief of pain associated with post partum cramping and dysmenorrhea.</p>
- Contraindications
- <p><strong>Contraindications:</strong> Peptic ulcer or active inflammatory diseases of the gastrointestinal system.<br>
Known or suspected hypersensitivity to the drug. Naproxen sodium should not be used in patients in whom acute asthmatic attacks, urticaria, rhinitis or other allergic manifestations are precipitated by ASA or other nonsteroidal anti-inflammatory agents. Fatal anaphylactoid reactions have occurred in such individuals.</p>
- Atc Code
- M01AE02
- Atc Item Name
- naproxen
- Pharma Manufacturer Name
- PHARMAFORTE SINGAPORE PTE LTD
